查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1868936

倒刺缝合线市场：按应用、产品类型、材质、最终用途和通路- 全球预测（2025-2032 年）

Barbed Suture Market by Application, Product Type, Material Type, End Use, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，带倒刺缝线市场规模将达到 11.6427 亿美元，复合年增长率为 12.12%。

关键市场统计数据
基准年 2024 4.6602亿美元
预计年份：2025年 5.2377亿美元
预测年份 2032 1,164,270,000 美元
复合年增长率 (%) 12.12%

倒刺缝线已成为外科缝合领域的革命性技术，它将机械创新与手术效率相结合，以满足外科医生和医疗护理流程不断变化的需求。透过在缝线长度方向上设置定向倒刺，这些缝线无需结扎，分散张力，并减少手术步骤。随着临床医生寻求更短的手术时间、更一致的伤口对合以及更好的美容效果，倒刺缝线在各个外科领域正得到越来越广泛的应用。

临床应用主要得益于手术效率和可重复性的显着提升，尤其是在微创手术中，打结操作难度较高。同时，製造商不断改进聚合物、倒刺结构以及针线连接完整性，以优化操作特性、抗拉强度和组织相容性。监管和外科医生培训计画持续影响应用模式，进而影响医院、门诊手术中心和专科诊所的采购决策。

实际上，这项技术正将讨论的焦点从简单的缝合工具转移到系统层面的考量，例如器械间的兼容性、库存合理化以及手术全期工作流程的重新设计。相关人员现在不仅从临床终点评估倒刺缝合线，还从其对供应链可靠性、消毒流程和手术室效率的经济影响等方面进行评估。因此，倒刺缝合线的创新处于材料科学、不断发展的外科技术和机构政策的交汇点，在评估市场机会和临床价值提案时，需要采取全面的观点。

外科创新、聚合物工程和不断发展的采购管道如何共同重塑带倒刺缝合线市场的临床应用和商业策略

过去几年，一系列变革性的变化正在重塑带倒刺缝合线的格局，这些变化主要受外科技术发展、材料科学进步以及医疗服务模式转变的推动。微创和内视镜手术的兴起拓展了无结缝合的应用范围，并促使器械不断改进，优先考虑低轮廓倒刺、更佳的无结固定以及与小直径手术通道的兼容性。这些临床因素促使外科协会与器械研发商加强合作，推动培训课程和最佳实践指南的更新。

评估2025年关税环境及其对整个外科耗材供应链的筹资策略、购买行为和商业计划的影响

2025年实施的关税政策变更为全球外科耗材供应链中的製造商、经销商和医疗系统带来了新的成本驱动因素。进口外科材料和成品医疗设备关税的提高，促使企业重新评估其筹资策略，实现供应商多元化，并优化其区域製造地，以缓解到岸成本压力。为此，一些公司加快了近岸外包的步伐，并重新谈判供应商合同，以维持价格竞争力并保障利润率。

全面的細項分析揭示了特定应用流程、材料选择、临床环境和通路如何共同决定临床应用模式和采购优先顺序。

对细分市场细微差别的分析揭示了临床方面、产品属性、材料特性、最终用途和通路等维度如何影响采用模式和策略重点。按应用领域划分，市场可分为心胸外科、普通外科、妇科、整形外科、整形与重组外科泌尿系统，并进一步细化到手术层面，例如心胸外科和普通外科开放性手术的微创手术与开放性手术、整形外科中的关节镜手术与关节重组手术、镜与重组外科中的美容和重组手术以及泌尿系统手术中的美容和重建手术以及泌尿外科开放性手术手术。这些手术细微差别会影响缝线的选择，决定其操作特性、抗拉强度要求和针头设计偏好。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 使用倒刺缝线改善组织缝合的机器人辅助手术应用日益广泛
  • 完全可吸收倒刺缝合线的研发取得了长足发展，减少了术后併发症和疤痕。
  • 提高整形外科和心血管外科手术中抗菌涂层倒刺缝线的监管核准
  • 增加对先进聚合物研究的投入，以提高新一代倒刺缝合线的耐久性和生物相容性。
  • 扩大倒刺缝合线在美容和重组外科手术的应用，以改善患者预后
  • 对成本优化策略的关注正在推动对带倒刺缝合线可重复使用输送系统的需求。
  • 随着整合倒刺缝线的数位手术平台的出现，即时手术导航成为可能。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 按应用分類的倒刺缝合线市场

  • 心胸外科
    • 微创
    • 开放性手术
  • 一般外科
    • 微创
    • 开放性手术
  • 妇科
    • 腹腔镜
    • 开放性手术
  • 整形外科
    • 关节镜
    • 关节重组
  • 整形和重组外科
    • 美丽
    • 重组
  • 泌尿系统
    • 内视镜手术
    • 开放性手术

9. 按产品类型分類的倒刺缝合线市场

  • 吸收性
  • 不可吸收

第十章 依材质类型分類的倒刺缝合线市场

  • 氧环己酮聚合体
  • Polyglactin910
  • Polyglycolic
  • 聚丙烯

第十一章 以最终用途分類的倒刺缝合线市场

  • 门诊手术中心
  • 诊所
  • 医院

第十二章 附倒刺缝合线市场（依通路划分）

  • 电子商务
  • 医院药房
  • 医疗用品商店
  • 批发商

第十三章 各地区附倒刺缝合线市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 附倒刺缝合线市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国带倒刺缝合线市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Medtronic plc
    • Ethicon, Inc.
    • B. Braun Melsungen AG
    • ConMed Corporation
    • Becton, Dickinson and Company
    • Integra LifeSciences Holdings Corporation
    • AngioDynamics, Inc.
    • Teleflex Incorporated
Product Code: MRR-DB30509545BA

The Barbed Suture Market is projected to grow by USD 1,164.27 million at a CAGR of 12.12% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 466.02 million
Estimated Year [2025] USD 523.77 million
Forecast Year [2032] USD 1,164.27 million
CAGR (%) 12.12%

Barbed sutures have emerged as a transformative thread in surgical closure, combining mechanical innovation with procedural efficiency to meet the evolving needs of surgeons and care pathways. These sutures eliminate the need for knot tying by incorporating directional barbs along the filament, which distribute tensile forces and reduce operative steps. As clinicians pursue shorter operating times, consistent wound approximation, and enhanced cosmetic outcomes, barbed sutures have gained traction across a diverse set of surgical disciplines.

Clinical adoption is driven by observable improvements in procedural ergonomics and reproducibility, particularly in minimally invasive approaches where knot tying is technically demanding. Concurrently, manufacturers are iterating on polymers, barb geometries, and needle-suture integration to optimize handling characteristics, tensile retention, and tissue compatibility. Regulatory scrutiny and surgeon training programs continue to shape adoption patterns, influencing procurement decisions across hospitals, ambulatory surgical centres, and specialty clinics.

In practice, the technology has shifted conversations from simple closure tools to systems-level considerations that include device-to-device compatibility, inventory rationalization, and perioperative workflow redesign. Stakeholders now evaluate barbed sutures not only on clinical endpoints but also on supply chain reliability, sterilization modalities, and economic impact on operating room throughput. Consequently, barbed suture innovation sits at the intersection of materials science, surgical technique evolution, and institutional policy, demanding a holistic view when assessing market opportunities and clinical value propositions.

How surgical technique innovation, polymer engineering, and evolving procurement channels are jointly reshaping clinical adoption and commercial strategies in the barbed suture market

The last several years have produced a series of transformative shifts reshaping the barbed suture landscape, driven by surgical technique evolution, material science advances, and shifting care delivery models. Minimally invasive and endoscopic procedures have expanded the use case for knotless closure, prompting device refinements that prioritize low-profile barbs, improved knotless anchoring, and compatibility with narrow working channels. These clinical drivers have catalyzed closer collaboration between surgical societies and device developers to update training curricula and best practice recommendations.

On the materials front, innovations in absorbable polymers and hybrid constructions have improved tensile retention and degradation profiles, enabling broader adoption in tissue types with varying healing kinetics. At the same time, nonabsorbable options remain relevant for indications where permanent mechanical support is desirable. Transitioning from traditional monofilaments to engineered blends has implications for manufacturing scale-up, quality control, and sterilization processes, which in turn affect supplier selection and cost structures.

Regulatory and reimbursement environments have also evolved, with payors increasingly focused on evidence of improved perioperative efficiency and reduced complication rates. This shift has encouraged manufacturers to prioritize real-world evidence generation alongside randomized clinical trials. Finally, distribution and procurement channels have diversified as e-commerce platforms and centralized hospital supply strategies alter how products reach the point of care. Collectively, these shifts create new opportunities for differentiation but also raise the bar for demonstrating clinical and economic value in diverse care settings.

Assessing the 2025 tariff environment and its consequential impact on sourcing strategies, procurement behavior, and commercial planning across surgical consumable supply chains

Tariff policy changes implemented in 2025 have introduced new cost considerations for manufacturers, distributors, and health systems that interact with global supply chains for surgical consumables. Increased duties on imported surgical materials and finished devices have prompted firms to revisit sourcing strategies, supplier diversification, and regional manufacturing footprints to mitigate landed cost pressures. In response, several companies accelerated nearshoring efforts or renegotiated supplier contracts to preserve competitive pricing while safeguarding margin profiles.

Hospitals and ambulatory settings felt the immediate effects through procurement cycles, where budget holders sought clarity on long-term pricing and contract stability. Some purchasers instituted longer-term sourcing agreements to lock in supply and protect against future tariff volatility, while others increased inventory buffers to smooth short-term disruptions. These operational responses underscored the importance of supply chain resilience planning and transparent cost modeling when evaluating surgical consumables.

Beyond procurement, the tariff environment altered strategic investment calculus for product launches and clinical rollouts. Manufacturers weighing expansion into particular regions reassessed total landed costs, time-to-market, and reimbursement alignment. As a result, value communication to clinicians and supply chain stakeholders emphasized lifecycle cost analyses and clinical efficiency gains that could offset tariff-induced price changes. In sum, the 2025 tariff landscape sharpened focus on regional supply strategies, margin protection, and evidence-based cost offsets as essential elements of commercial planning.

Comprehensive segmentation analysis revealing how application-specific procedures, material choices, care settings, and distribution channels collectively determine clinical adoption patterns and procurement priorities

A nuanced view of segmentation reveals how clinical, product, material, end-use, and distribution dimensions shape adoption patterns and strategic priorities. Based on Application, the market spans Cardiothoracic, General Surgery, Gynecological, Orthopaedic, Plastic & Reconstructive, and Urology, with granular procedure-level distinctions such as Minimally Invasive and Open approaches for Cardiothoracic and General Surgery, Laparoscopic and Open for Gynecological procedures, Arthroscopy and Joint Reconstruction for Orthopaedics, Cosmetic and Reconstructive for Plastic surgery, and Endoscopic and Open for Urology. These procedural nuances influence suture selection by dictating handling characteristics, tensile retention requirements, and needle design preferences.

Based on Product Type, the landscape is defined by Absorbable and Nonabsorbable options, each aligning with specific clinical endpoints related to tissue healing timelines and long-term mechanical support needs. Based on Material Type, manufacturers deploy a range of polymers such as Polydioxanone, Polyglactin 910, Polyglycolic Acid, and Polypropylene, where each material's degradation profile, tensile behavior, and tissue reactivity inform clinical suitability across applications.

Based on End Use, settings include Ambulatory Surgical Centres, Clinics, and Hospitals, which differ in case mix, procurement sophistication, and inventory management practices; ambulatory environments often prioritize single-use convenience and efficiency, while hospitals emphasize breadth of supply and compatibility with diverse surgical teams. Based on Distribution Channel, products reach the point of care through E-Commerce, Hospital Pharmacies, Medical Supply Stores, and Wholesale Distributors, with each channel imposing distinct commercial requirements such as digital catalog presence, contract pricing mechanisms, and logistical reliability. Taken together, these segmentation lenses demonstrate that successful product positioning requires synchronous alignment across clinical use cases, material science, care setting workflows, and channel strategies.

Regional dynamics and healthcare system variations across the Americas, Europe Middle East & Africa, and Asia-Pacific that shape regulatory pathways, procurement behavior, and clinical adoption trends

Regional dynamics exert a strong influence on regulatory pathways, clinical practice patterns, and supply chain architecture, shaping strategic priorities in each geography. In the Americas, established hospital systems and a robust private sector create a context where clinical evidence and hospital procurement cycles drive adoption, and where payer expectations about cost-effectiveness increasingly inform purchasing decisions. This drives an emphasis on clinical trials, surgeon training programs, and integrated hospital partnerships to demonstrate procedural efficiency and outcomes benefits.

In Europe, Middle East & Africa, variation in regulatory regimes and healthcare funding models produces heterogeneous adoption landscapes. In several markets, national procurement programs and centralized tenders emphasize value-based pricing and long-term supplier reliability, while private hospitals seek differentiated technologies that enhance cosmetic and functional outcomes. Across these regions, local regulatory alignment and targeted clinical education programs are critical to accelerating acceptance.

The Asia-Pacific region presents a mix of mature urban centers and rapidly developing healthcare infrastructure, leading to high growth potential for technologies that balance cost-effectiveness with clinical performance. Local manufacturing capabilities, government procurement policies, and a rising prevalence of minimally invasive procedures influence product demand. Consequently, regional strategies must account for differing clinical pathways, price sensitivity, and opportunities for localized partnerships to scale adoption efficiently.

Insights on corporate strategies, partnership models, and evidence generation tactics that leading companies deploy to advance product adoption and expand surgical closure portfolios

Corporate strategies among leading firms reflect a blend of product portfolio expansion, clinical evidence generation, and channel optimization. Many companies have prioritized iterative improvements in barb geometry, needle integration, and polymer formulations to enhance handling and reduce tissue drag, while others have pursued diversification across both absorbable and nonabsorbable offerings to address a wider array of clinical indications. Strategic collaborations between device innovators and surgical training organizations have emerged as a common approach to accelerate surgeon familiarity and preference formation.

Mergers and acquisitions, selective licensing, and distribution partnerships have been used to fill pipeline gaps, broaden geographic reach, and secure manufacturing scale. Concurrently, several firms have invested in real-world evidence programs and registry data to document outcomes in routine practice, aiming to support hospital purchasing committees and payer dialogues. Distribution strategies have shifted toward multi-channel approaches that combine direct hospital contracting, e-commerce presence for smaller clinics, and partnerships with wholesale distributors to improve access in decentralized markets.

Manufacturers that succeed tend to align product design with clear clinical advantages, demonstrate consistent supply reliability, and provide robust training and post-market surveillance support. As clinical expectations evolve, leading companies are also exploring adjunct services such as digital training platforms, suture-compatible instrumentation, and bundled solutions that streamline adoption across care settings.

Actionable recommendations for product development, evidence generation, and supply chain strategies that enable manufacturers to accelerate adoption and defend commercial positions

Industry leaders can take several practical steps to translate market intelligence into competitive advantage and sustainable growth. First, aligning R&D priorities with high-frequency procedural needs and surgeon pain points will ensure that material and design improvements yield demonstrable clinical benefits. Prioritizing polymers and barb geometries that reduce operative time while maintaining tissue integrity will resonate across minimally invasive and open procedures.

Second, strengthening clinical evidence through pragmatic trials and real-world registries will support procurement conversations and payer engagement. By emphasizing outcomes that matter to hospitals-such as reduced operative time, lower complication rates, and improved cosmetic results-manufacturers can present a compelling total cost of care narrative. Third, optimizing supply chain resilience by diversifying suppliers, evaluating nearshoring opportunities, and enhancing inventory transparency will mitigate tariff-related and logistical risks while protecting margin and service levels.

Fourth, tailoring commercial models to end-use settings and distribution channel preferences will improve market penetration; ambulatory centres may respond to simplified procurement and bundled offerings, whereas hospitals may prioritize long-term contracts and robust post-market support. Finally, investing in surgeon education and integrated adoption programs that combine hands-on training, proctoring, and digital learning will accelerate preference formation and long-term product utilization.

Transparent, multi-source research methodology combining clinical literature review, expert interviews, and primary stakeholder engagement to ensure robust and triangulated market insights

The research approach combines systematic literature review, expert interviews, and primary data collection to produce a rigorous, triangulated set of insights. Peer-reviewed clinical studies, regulatory filings, and device labeling were examined to build a clinical baseline and to identify material and performance differentiators. Complementing secondary sources, in-depth interviews with key opinion leaders, procurement specialists, and distribution partners provided qualitative context on adoption drivers, training needs, and channel dynamics.

Primary data collection included structured discussions with surgical practitioners across specialties and with supply chain stakeholders in hospitals and ambulatory settings to validate procedural preferences and purchasing behaviors. Market intelligence on manufacturing and distribution practices was derived from supplier disclosures, public filings, and direct engagement with distribution channels to assess logistical constraints and contractual norms. Analytical methods emphasized cross-validation, where qualitative insights were corroborated against documented clinical outcomes and regulatory trends to ensure robustness.

Throughout the methodology, care was taken to avoid overreliance on any single data source; instead, findings were synthesized using triangulation to present balanced perspectives. The research team applied sensitivity analyses to interpret implications under varying operational conditions, and emphasized transparency in assumptions to support confident decision-making by commercial and clinical stakeholders.

Concluding synthesis on how clinical advantages, material innovation, and procurement dynamics will determine long-term success for barbed suture stakeholders

Barbed suture technology occupies a strategic niche at the convergence of surgical innovation, materials science, and health system imperatives for efficiency and outcomes improvement. Clinical momentum is strongest where knotless closure materially eases technical burdens, particularly in minimally invasive and endoscopic procedures, and where polymers and barb designs align with tissue-specific healing characteristics. Distribution and procurement behaviors continue to evolve as e-commerce platforms, centralized hospital purchasing, and wholesale partnerships reshape how products reach the point of care.

Regulatory landscapes and tariff dynamics have underscored the need for resilient supply chain models and clear economic narratives that demonstrate value beyond unit price. Companies that integrate clinical evidence generation, surgical education, and supply chain diversification into coherent commercial strategies are better positioned to navigate regional differences and procedural nuances. Ultimately, durable success will favor those who translate technical advantages into measurable clinical and operational outcomes that are recognized by surgeons, hospital procurement teams, and health system payers alike.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of robotic-assisted surgeries using barbed sutures for enhanced tissue approximation
  • 5.2. Surge in development of fully absorbable barbed sutures to reduce postoperative complications and scarring
  • 5.3. Increasing regulatory approvals for antimicrobial coated barbed sutures in orthopedic and cardiovascular procedures
  • 5.4. Growing investment in advanced polymer research for next-generation barbed suture durability and biocompatibility
  • 5.5. Expansion of barbed suture applications in cosmetic and reconstructive procedures to improve patient outcomes
  • 5.6. Focus on cost optimization strategies driving demand for reusable delivery systems in barbed suturing
  • 5.7. Emergence of digital surgical platforms integrating barbed sutures for real time procedural guidance

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Barbed Suture Market, by Application

  • 8.1. Cardiothoracic
    • 8.1.1. Minimally Invasive
    • 8.1.2. Open
  • 8.2. General Surgery
    • 8.2.1. Minimally Invasive
    • 8.2.2. Open
  • 8.3. Gynecological
    • 8.3.1. Laparoscopic
    • 8.3.2. Open
  • 8.4. Orthopaedic
    • 8.4.1. Arthroscopy
    • 8.4.2. Joint Reconstruction
  • 8.5. Plastic & Reconstructive
    • 8.5.1. Cosmetic
    • 8.5.2. Reconstructive
  • 8.6. Urology
    • 8.6.1. Endoscopic
    • 8.6.2. Open

9. Barbed Suture Market, by Product Type

  • 9.1. Absorbable
  • 9.2. Nonabsorbable

10. Barbed Suture Market, by Material Type

  • 10.1. Polydioxanone
  • 10.2. Polyglactin 910
  • 10.3. Polyglycolic Acid
  • 10.4. Polypropylene

11. Barbed Suture Market, by End Use

  • 11.1. Ambulatory Surgical Centres
  • 11.2. Clinics
  • 11.3. Hospitals

12. Barbed Suture Market, by Distribution Channel

  • 12.1. E-Commerce
  • 12.2. Hospital Pharmacies
  • 12.3. Medical Supply Stores
  • 12.4. Wholesale Distributors

13. Barbed Suture Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Barbed Suture Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Barbed Suture Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Medtronic plc
    • 16.3.2. Ethicon, Inc.
    • 16.3.3. B. Braun Melsungen AG
    • 16.3.4. ConMed Corporation
    • 16.3.5. Becton, Dickinson and Company
    • 16.3.6. Integra LifeSciences Holdings Corporation
    • 16.3.7. AngioDynamics, Inc.
    • 16.3.8. Teleflex Incorporated

LIST OF FIGURES

  • FIGURE 1. GLOBAL BARBED SUTURE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BARBED SUTURE MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BARBED SUTURE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BARBED SUTURE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BARBED SUTURE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BARBED SUTURE MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BARBED SUTURE MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BARBED SUTURE MARKET SIZE, BY END USE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BARBED SUTURE MARKET SIZE, BY END USE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BARBED SUTURE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BARBED SUTURE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BARBED SUTURE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS BARBED SUTURE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA BARBED SUTURE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA BARBED SUTURE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BARBED SUTURE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE BARBED SUTURE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST BARBED SUTURE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA BARBED SUTURE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BARBED SUTURE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL BARBED SUTURE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN BARBED SUTURE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC BARBED SUTURE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION BARBED SUTURE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS BARBED SUTURE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 BARBED SUTURE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO BARBED SUTURE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL BARBED SUTURE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BARBED SUTURE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. BARBED SUTURE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BARBED SUTURE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BARBED SUTURE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BARBED SUTURE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BARBED SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BARBED SUTURE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BARBED SUTURE MARKET SIZE, BY CARDIOTHORACIC, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BARBED SUTURE MARKET SIZE, BY CARDIOTHORACIC, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BARBED SUTURE MARKET SIZE, BY CARDIOTHORACIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BARBED SUTURE MARKET SIZE, BY CARDIOTHORACIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BARBED SUTURE MARKET SIZE, BY CARDIOTHORACIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BARBED SUTURE MARKET SIZE, BY CARDIOTHORACIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BARBED SUTURE MARKET SIZE, BY CARDIOTHORACIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BARBED SUTURE MARKET SIZE, BY CARDIOTHORACIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BARBED SUTURE MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BARBED SUTURE MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BARBED SUTURE MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BARBED SUTURE MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BARBED SUTURE MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BARBED SUTURE MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BARBED SUTURE MARKET SIZE, BY OPEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BARBED SUTURE MARKET SIZE, BY OPEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BARBED SUTURE MARKET SIZE, BY OPEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BARBED SUTURE MARKET SIZE, BY OPEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BARBED SUTURE MARKET SIZE, BY OPEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BARBED SUTURE MARKET SIZE, BY OPEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BARBED SUTURE MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BARBED SUTURE MARKET SIZE, BY GENERAL SURGERY, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BARBED SUTURE MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BARBED SUTURE MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BARBED SUTURE MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BARBED SUTURE MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BARBED SUTURE MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BARBED SUTURE MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BARBED SUTURE MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BARBED SUTURE MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BARBED SUTURE MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BARBED SUTURE MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BARBED SUTURE MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BARBED SUTURE MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BARBED SUTURE MARKET SIZE, BY OPEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BARBED SUTURE MARKET SIZE, BY OPEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BARBED SUTURE MARKET SIZE, BY OPEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BARBED SUTURE MARKET SIZE, BY OPEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BARBED SUTURE MARKET SIZE, BY OPEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BARBED SUTURE MARKET SIZE, BY OPEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BARBED SUTURE MARKET SIZE, BY GYNECOLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BARBED SUTURE MARKET SIZE, BY GYNECOLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BARBED SUTURE MARKET SIZE, BY GYNECOLOGICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BARBED SUTURE MARKET SIZE, BY GYNECOLOGICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BARBED SUTURE MARKET SIZE, BY GYNECOLOGICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BARBED SUTURE MARKET SIZE, BY GYNECOLOGICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BARBED SUTURE MARKET SIZE, BY GYNECOLOGICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BARBED SUTURE MARKET SIZE, BY GYNECOLOGICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BARBED SUTURE MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BARBED SUTURE MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BARBED SUTURE MARKET SIZE, BY LAPAROSCOPIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BARBED SUTURE MARKET SIZE, BY LAPAROSCOPIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BARBED SUTURE MARKET SIZE, BY LAPAROSCOPIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BARBED SUTURE MARKET SIZE, BY LAPAROSCOPIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BARBED SUTURE MARKET SIZE, BY OPEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BARBED SUTURE MARKET SIZE, BY OPEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BARBED SUTURE MARKET SIZE, BY OPEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BARBED SUTURE MARKET SIZE, BY OPEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BARBED SUTURE MARKET SIZE, BY OPEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BARBED SUTURE MARKET SIZE, BY OPEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BARBED SUTURE MARKET SIZE, BY ORTHOPAEDIC, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BARBED SUTURE MARKET SIZE, BY ORTHOPAEDIC, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BARBED SUTURE MARKET SIZE, BY ORTHOPAEDIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BARBED SUTURE MARKET SIZE, BY ORTHOPAEDIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BARBED SUTURE MARKET SIZE, BY ORTHOPAEDIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BARBED SUTURE MARKET SIZE, BY ORTHOPAEDIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BARBED SUTURE MARKET SIZE, BY ORTHOPAEDIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BARBED SUTURE MARKET SIZE, BY ORTHOPAEDIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BARBED SUTURE MARKET SIZE, BY ARTHROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BARBED SUTURE MARKET SIZE, BY ARTHROSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BARBED SUTURE MARKET SIZE, BY ARTHROSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BARBED SUTURE MARKET SIZE, BY ARTHROSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BARBED SUTURE MARKET SIZE, BY ARTHROSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BARBED SUTURE MARKET SIZE, BY ARTHROSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BARBED SUTURE MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BARBED SUTURE MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BARBED SUTURE MARKET SIZE, BY JOINT RECONSTRUCTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BARBED SUTURE MARKET SIZE, BY JOINT RECONSTRUCTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BARBED SUTURE MARKET SIZE, BY JOINT RECONSTRUCTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BARBED SUTURE MARKET SIZE, BY JOINT RECONSTRUCTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BARBED SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BARBED SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BARBED SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BARBED SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BARBED SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BARBED SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BARBED SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BARBED SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BARBED SUTURE MARKET SIZE, BY COSMETIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BARBED SUTURE MARKET SIZE, BY COSMETIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BARBED SUTURE MARKET SIZE, BY COSMETIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BARBED SUTURE MARKET SIZE, BY COSMETIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BARBED SUTURE MARKET SIZE, BY COSMETIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BARBED SUTURE MARKET SIZE, BY COSMETIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BARBED SUTURE MARKET SIZE, BY RECONSTRUCTIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BARBED SUTURE MARKET SIZE, BY RECONSTRUCTIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BARBED SUTURE MARKET SIZE, BY RECONSTRUCTIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BARBED SUTURE MARKET SIZE, BY RECONSTRUCTIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BARBED SUTURE MARKET SIZE, BY RECONSTRUCTIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BARBED SUTURE MARKET SIZE, BY RECONSTRUCTIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BARBED SUTURE MARKET SIZE, BY UROLOGY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BARBED SUTURE MARKET SIZE, BY UROLOGY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BARBED SUTURE MARKET SIZE, BY UROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BARBED SUTURE MARKET SIZE, BY UROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BARBED SUTURE MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BARBED SUTURE MARKET SIZE, BY UROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BARBED SUTURE MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BARBED SUTURE MARKET SIZE, BY UROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BARBED SUTURE MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BARBED SUTURE MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BARBED SUTURE MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BARBED SUTURE MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BARBED SUTURE MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BARBED SUTURE MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BARBED SUTURE MARKET SIZE, BY OPEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BARBED SUTURE MARKET SIZE, BY OPEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BARBED SUTURE MARKET SIZE, BY OPEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BARBED SUTURE MARKET SIZE, BY OPEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BARBED SUTURE MARKET SIZE, BY OPEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BARBED SUTURE MARKET SIZE, BY OPEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BARBED SUTURE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BARBED SUTURE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BARBED SUTURE MARKET SIZE, BY ABSORBABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BARBED SUTURE MARKET SIZE, BY ABSORBABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BARBED SUTURE MARKET SIZE, BY ABSORBABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BARBED SUTURE MARKET SIZE, BY ABSORBABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BARBED SUTURE MARKET SIZE, BY ABSORBABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BARBED SUTURE MARKET SIZE, BY ABSORBABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BARBED SUTURE MARKET SIZE, BY NONABSORBABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BARBED SUTURE MARKET SIZE, BY NONABSORBABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BARBED SUTURE MARKET SIZE, BY NONABSORBABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BARBED SUTURE MARKET SIZE, BY NONABSORBABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BARBED SUTURE MARKET SIZE, BY NONABSORBABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BARBED SUTURE MARKET SIZE, BY NONABSORBABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BARBED SUTURE MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BARBED SUTURE MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BARBED SUTURE MARKET SIZE, BY POLYDIOXANONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BARBED SUTURE MARKET SIZE, BY POLYDIOXANONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BARBED SUTURE MARKET SIZE, BY POLYDIOXANONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BARBED SUTURE MARKET SIZE, BY POLYDIOXANONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BARBED SUTURE MARKET SIZE, BY POLYDIOXANONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BARBED SUTURE MARKET SIZE, BY POLYDIOXANONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BARBED SUTURE MARKET SIZE, BY POLYGLACTIN 910, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BARBED SUTURE MARKET SIZE, BY POLYGLACTIN 910, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BARBED SUTURE MARKET SIZE, BY POLYGLACTIN 910, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BARBED SUTURE MARKET SIZE, BY POLYGLACTIN 910, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BARBED SUTURE MARKET SIZE, BY POLYGLACTIN 910, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BARBED SUTURE MARKET SIZE, BY POLYGLACTIN 910, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BARBED SUTURE MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BARBED SUTURE MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BARBED SUTURE MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BARBED SUTURE MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BARBED SUTURE MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BARBED SUTURE MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BARBED SUTURE MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BARBED SUTURE MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BARBED SUTURE MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BARBED SUTURE MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BARBED SUTURE MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BARBED SUTURE MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BARBED SUTURE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BARBED SUTURE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BARBED SUTURE MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BARBED SUTURE MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BARBED SUTURE MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BARBED SUTURE MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BARBED SUTURE MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BARBED SUTURE MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BARBED SUTURE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BARBED SUTURE MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BARBED SUTURE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BARBED SUTURE MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BARBED SUTURE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BARBED SUTURE MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BARBED SUTURE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BARBED SUTURE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BARBED SUTURE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BARBED SUTURE MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BARBED SUTURE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BARBED SUTURE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BARBED SUTURE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BARBED SUTURE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BARBED SUTURE MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BARBED SUTURE MARKET SIZE, BY E-COMMERCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BARBED SUTURE MARKET SIZE, BY E-COMMERCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BARBED SUTURE MARKET SIZE, BY E-COMMERCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BARBED SUTURE MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BARBED SUTURE MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BARBED SUTURE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BARBED SUTURE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BARBED SUTURE MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BARBED SUTURE MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BARBED SUTURE MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BARBED SUTURE MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BARBED SUTURE MARKET SIZE, BY MEDICAL SUPPLY STORES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BARBED SUTURE MARKET SIZE, BY MEDICAL SUPPLY STORES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BARBED SUTURE MARKET SIZE, BY MEDICAL SUPPLY STORES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BARBED SUTURE MARKET SIZE, BY MEDICAL SUPPLY STORES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BARBED SUTURE MARKET SIZE, BY MEDICAL SUPPLY STORES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BARBED SUTURE MARKET SIZE, BY MEDICAL SUPPLY STORES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BARBED SUTURE MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BARBED SUTURE MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BARBED SUTURE MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BARBED SUTURE MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BARBED SUTURE MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BARBED SUTURE MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL BARBED SUTURE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL BARBED SUTURE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS BARBED SUTURE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS BARBED SUTURE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS BARBED SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS BARBED SUTURE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS BARBED SUTURE MARKET SIZE, BY CARDIOTHORACIC, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS BARBED SUTURE MARKET SIZE, BY CARDIOTHORACIC, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS BARBED SUTURE MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS BARBED SUTURE MARKET SIZE, BY GENERAL SURGERY, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS BARBED SUTURE MARKET SIZE, BY GYNECOLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS BARBED SUTURE MARKET SIZE, BY GYNECOLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS BARBED SUTURE MARKET SIZE, BY ORTHOPAEDIC, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS BARBED SUTURE MARKET SIZE, BY ORTHOPAEDIC, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS BARBED SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS BARBED SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS BARBED SUTURE MARKET SIZE, BY UROLOGY, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS BARBED SUTURE MARKET SIZE, BY UROLOGY, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS BARBED SUTURE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS BARBED SUTURE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS BARBED SUTURE MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS BARBED SUTURE MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS BARBED SUTURE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS BARBED SUTURE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS BARBED SUTURE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS BARBED SUTURE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA BARBED SUTURE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA BARBED SUTURE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA BARBED SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA BARBED SUTURE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA BARBED SUTURE MARKET SIZE, BY CARDIOTHORACIC, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA BARBED SUTURE MARKET SIZE, BY CARDIOTHORACIC, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA BARBED SUTURE MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA BARBED SUTURE MARKET SIZE, BY GENERAL SURGERY, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA BARBED SUTURE MARKET SIZE, BY GYNECOLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA BARBED SUTURE MARKET SIZE, BY GYNECOLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA BARBED SUTURE MARKET SIZE, BY ORTHOPAEDIC, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA BARBED SUTURE MARKET SIZE, BY ORTHOPAEDIC, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA BARBED SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA BARBED SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA BARBED SUTURE MARKET SIZE, BY UROLOGY, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA BARBED SUTURE MARKET SIZE, BY UROLOGY, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA BARBED SUTURE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA BARBED SUTURE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA BARBED SUTURE MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA BARBED SUTURE MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA BARBED SUTURE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA BARBED SUTURE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA BARBED SUTURE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA BARBED SUTURE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA BARBED SUTURE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA BARBED SUTURE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA BARBED SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA BARBED SUTURE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA BARBED SUTURE MARKET SIZE, BY CARDIOTHORACIC, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA BARBED SUTURE MARKET SIZE, BY CARDIOTHORACIC, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA BARBED SUTURE MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA BARBED SUTURE MARKET SIZE, BY GENERAL SURGERY, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA BARBED SUTURE MARKET SIZE, BY GYNECOLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA BARBED SUTURE MARKET SIZE, BY GYNECOLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA BARBED SUTURE MARKET SIZE, BY ORTHOPAEDIC, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA BARBED SUTURE MARKET SIZE, BY ORTHOPAEDIC, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA BARBED SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA BARBED SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA BARBED SUTURE MARKET SIZE, BY UROLOGY, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA BARBED SUTURE MARKET SIZE, BY UROLOGY, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA BARBED SUTURE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA BARBED SUTURE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA BARBED SUTURE MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA BARBED SUTURE MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA BARBED SUTURE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 284. LATIN AMERICA BARBED SUTURE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA BARBED SUTURE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 286. LATIN AMERICA BARBED SUTURE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA BARBED SUTURE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA BARBED SUTURE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA BARBED SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA BARBED SUTURE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA BARBED SUTURE MARKET SIZE, BY CARDIOTHORACIC, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA BARBED SUTURE MARKET SIZE, BY CARDIOTHORACIC, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA BARBED SUTURE MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA BARBED SUTURE MARKET SIZE, BY GENERAL SURGERY, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA BARBED SUTURE MARKET SIZE, BY GYNECOLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA BARBED SUTURE MARKET SIZE, BY GYNECOLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA BARBED SUTURE MARKET SIZE, BY ORTHOPAEDIC, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA BARBED SUTURE MARKET SIZE, BY ORTHOPAEDIC, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA BARBED SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA BARBED SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA BARBED SUTURE MARKET SIZE, BY UROLOGY, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA BARBED SUTURE MARKET SIZE, BY UROLOGY, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA BARBED SUTURE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA BARBED SUTURE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA BARBED SUTURE MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA BARBED SUTURE MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA BARBED SUTURE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA BARBED SUTURE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPE, MIDDLE EAST & AFRICA BARBED SUTURE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPE, MIDDLE EAST & AFRICA BARBED SUTURE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPE BARBED SUTURE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPE BARBED SUTURE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPE BARBED SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPE BARBED SUTURE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPE BARBED SUTURE MARKET SIZE, BY CARDIOTHORACIC, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPE BARBED SUTURE MARKET SIZE, BY CARDIOTHORACIC, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPE BARBED SUTURE MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPE BARBED SUTURE MARKET SIZE, BY GENERAL SURGERY, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPE BARBED SUTURE MARKET SIZE, BY GYNECOLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPE BARBED SUTURE MARKET SIZE, BY GYNECOLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 321. EUROPE BARBED SUTURE MARKET SIZE, BY ORTHOPAEDIC, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPE BARBED SUTURE MARKET SIZE, BY ORTHOPAEDIC, 2025-2032 (USD MILLION)
  • TABLE 323. EUROPE BARBED SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE, 2018-2024 (USD MILLION)
  • TABLE 324. EUROPE BARBED SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE, 2025-2032 (USD MILLION)
  • TABLE 325. EUROPE BARBED SUTURE MARKET SIZE, BY UROLOGY, 2018-2024 (USD MILLION)
  • TABLE 326. EUROPE BARBED SUTURE MARKET SIZE, BY UROLOGY, 2025-2032 (USD MILLION)
  • TABLE 327. EUROPE BARBED SUTURE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 328. EUROPE BARBED SUTURE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 329. EUROPE BARBED SUTURE MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 330. EUROPE BARBED SUTURE MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 331. EUROPE BARBED SUTURE MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 332. EUROPE BARBED SUTURE MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 333. EUROPE BARBED SUTURE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 334. EUROPE BARBED SUTURE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 335. MIDDLE EAST BARBED SUTURE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 336. MIDDLE EAST BARBED SUTURE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 337. MIDDLE EAST BARBED SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 338. MIDDLE EAST BARBED SUTURE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 339. MIDDLE EAST BARBED SUTURE MARKET SIZE, BY CARDIOTHORACIC, 2018-2024 (USD MILLION)
  • TABLE 340. MIDDLE EAST BARBED SUTURE MARKET SIZE, BY CARDIOTHORACIC, 2025-2032 (USD MILLION)
  • TABLE 341. MIDDLE EAST BARBED SUTURE MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
  • TABLE 342. MIDDLE EAST BARBED SUTURE MARKET SIZE, BY GENERAL SURGERY, 2025-2032 (USD MILLION)
  • TABLE 343. MIDDLE EAST BARBED SUTURE MARKET SIZE, BY GYNECOLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 344. MIDDLE EAST BARBED SUTURE MARKET SIZE, BY GYNECOLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 345. MIDDLE EAST BARBED SUTURE M